INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 413m ago
HOUSE PTR12m ago
SEC 13F12m ago
ROBINHOOD CHAIN12m ago
SEC FORM 4/Grant or awardVerified data

Gassen William reported OSCR

Director · Oscar Health, Inc. · Oscar Health, Inc. — Deferred Stock Unit

Side
A
Value
$21K
Shares
1,220
Price
$16.9
Executed
Jan 8, 2026
Disclosed
Jan 12, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 8 executedJan 12, 2026 disclosed

OSCR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
17/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+9 / 25

$21K reported value · 32.5% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · OSCR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    PD
    Plouffe DavidDirector
    OSCROscar Health, Inc.
    Grant or award
    		A$21K
    641 sh
    		Oct 8, 2026Oct 13, 2026
    traded Oct 8, 2026
    		+5dSEC FORM 4

    Evidence

    19
    GW
    Gassen WilliamDirector
    OSCROscar Health, Inc.
    Grant or award
    		A$23K
    698 sh
    		Oct 8, 2026Oct 13, 2026
    traded Oct 8, 2026
    		+5dSEC FORM 4

    Evidence

    23
    MA
    McAnaney AdamChief Legal Officer
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$286K
    9,092 sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    24
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$988K
    31.4K sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    17
    BV
    Baltrus VictoriaChief Accounting Officer
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$30K
    958 sh
    		Sep 3, 2026Sep 8, 2026
    traded Sep 3, 2026
    		+5dSEC FORM 4

    Evidence

    15
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M$1.46M
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    6
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    14
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    48
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale
    		SELL$18.20M
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    10
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    10
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    41
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale
    		SELL$4.62M
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    19
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M$5.85M
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    14
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion
    		C—
    600.0K sh
    		Aug 27, 2026Aug 31, 2026
    traded Aug 27, 2026
    		+4dSEC FORM 4

    Evidence

    6
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Option exercise
    		M—
    150.0K sh
    		Aug 28, 2026Aug 31, 2026
    traded Aug 28, 2026
    		+3dSEC FORM 4

    Evidence

    1
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$54K
    1,799 sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    22
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$17.49M
    591.2K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    50.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    10
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$3,069
    102 sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    0
    SM
    Schlosser MarioDirector
    OSCROscar Health, Inc.
    Derivative conversion · 10b5-1 plan
    		C—
    50.0K sh
    		Jun 23, 2026Jun 25, 2026
    traded Jun 23, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001954883-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 8, 2026
    Published
    Jan 12, 2026
    Ingested by INSIDER
    Nov 5, 04:23 UTC
    Last re-read
    Nov 5, 04:23 UTC

    Extracted facts

    Filer
    Gassen William
    Role
    Director
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Oscar Health, Inc. — Deferred Stock Unit
    Ticker
    OSCR
    Shares
    1,220
    Price per share
    $16.9
    Value
    $20,618
    Execution date (reported)
    Jan 8, 2026
    Owned after transaction
    4,969 shares
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 1,220
    • Price: $16.9

    = $20,618

    What this establishes

    Gassen William filed this Form 4 reporting a grant or award of OSCR on Jan 8, 2026. It became public on Jan 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Gassen Williamcik:0001954883
    Issuer
    Oscar Health, Inc.cik:0001568651

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.